Sp25

GI MALIGNANCIES

Date
May 18, 2024

Presenter

Speaker Image for Wai Keung Leung
University of Hong Kong Li Ka Shing Faculty of Medicine

Tracks

Related Products

Thumbnail for VONOPRAZAN-BASED DUAL AND TRIPLE THERAPY VERSUS BISMUTH-BASED QUADRUPLE THERAPY AS FIRST-LINE THERAPY FOR HELICOBACTER PYLORI INFECTION IN CHINA: A THREE-ARMED, RANDOMIZED CLINICAL TRIAL
VONOPRAZAN-BASED DUAL AND TRIPLE THERAPY VERSUS BISMUTH-BASED QUADRUPLE THERAPY AS FIRST-LINE THERAPY FOR HELICOBACTER PYLORI INFECTION IN CHINA: A THREE-ARMED, RANDOMIZED CLINICAL TRIAL
BACKGROUND AND AIM: We aimed to compare efficacy of vonoprazan-based therapies and bismuth-based quadruple therapy as first-line treatment for _Helicobacter pylori_ (_H. pylori_) infection in Southern China, where high primary resistance rates of clarithromycin and levofloxacin (>30%) exist…
Thumbnail for ASSOCIATION BETWEEN GLYCEMIC CONTROL AND COLORECTAL ADENOMA AND CANCER RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A POPULATION-BASED COHORT STUDY
ASSOCIATION BETWEEN GLYCEMIC CONTROL AND COLORECTAL ADENOMA AND CANCER RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A POPULATION-BASED COHORT STUDY
BACKGROUND: Whether glycemic control influences the risk of colonic adenoma and colorectal cancer (CRC) development is unknown…
Thumbnail for GLOBAL HEALTH INEQUALITY ANALYSIS OF PREMATURE MORTALITY RELATED TO PEPTIC ULCER DISEASE: A SYSTEMATIC ANALYSIS BASED ON GLOBAL BURDEN OF DISEASE
GLOBAL HEALTH INEQUALITY ANALYSIS OF PREMATURE MORTALITY RELATED TO PEPTIC ULCER DISEASE: A SYSTEMATIC ANALYSIS BASED ON GLOBAL BURDEN OF DISEASE
OBJECTIVES: Despite the declining incidence and mortality rates of peptic ulcer disease (PUD) over the past three decades, there remains an uneven distribution of disease burden in countries with varying sociodemographic levels…
Thumbnail for Best of DDW in Chinese
Best of DDW in Chinese
SOCIETY: AGA This session brings Chinese speaking experts together to provide a broad overview highlighting the best of AGA programming at DDW 2024 for Chinese speaking audiences…